Palisade Bio, Inc. Profile Avatar - Palmy Investing

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract…

Biotechnology
US, Carlsbad [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Palisade Bio, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PALI's Analysis
CIK: 1357459 CUSIP: 696389105 ISIN: US6963892046 LEI: - UEI: -
Secondary Listings
PALI has no secondary listings inside our databases.